
This study, based on a post hoc analysis of the PROTECT cohort study, assessed the association between high-sensitivity cardiac troponin I (hs-cTnI) and conventional cardiac troponin I (cTnI) with PE risk classifications and outcomes in hemodynamically stable PE patients. Of 834 participants, elevated cTnI (16.7%) was linked to a higher likelihood of complications within 30 days, whereas hs-cTnI elevation showed no significant association. Hs-cTnI identified modest troponin elevations but didn't offer additional clinical value compared to cTnI. The findings suggest that hs-cTnI may overestimate risk in stable PE patients, questioning its utility in such cases.
Like
Save
Share